Journal
Blood Advances
Publication Date
12-14-2021
Volume
5
Issue
23
First Page
5179
Last Page
5189
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2021004765
Rights and Permissions
Bond DA, Switchenko JM, Villa D, Maddocks K, Churnetski M, Gerrie AS, Goyal S, Shanmugasundaram K, Calzada O, Kolla B, Bachanova V, Gerson JN, Barta SK, Hill BT, Sawalha Y, Martin P, Maldonado E, Gordon M, Danilov AV, Grover NS, Mathews S, Burkart M, Karmali R, Ghosh N, Park SI, Epperla N, Badar T, Guo J, Hamadani M, Fenske TS, Malecek MK, Kahl BS, Flowers CR, Blum KA, Cohen JB. Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy. Blood Adv. 2021 Dec 14;5(23):5179-5189. doi: 10.1182/bloodadvances.2021004765. https://ashpublications.org/bloodadvances/article/5/23/5179/476879/Early-relapse-identifies-MCL-patients-with Copyright 2021 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Bond, David A.; Malecek, Mary-Kate; Kahl, Brad S.; and et al, "Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy." Blood Advances. 5, 23. 5179 - 5189. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11184
Supplemental Tables 1-5
